Author:
Velayos Fernando S.,Dusendang Jennifer R.,Schmittdiel Julie A.
Funder
Kaiser Foundation Research Institute
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Harpaz R, Dahl RM, Dooling KL. Prevalence of Immunosuppression Among US Adults, 2013. JAMA. 2016;316(23):2547-2548.
2. Goodsall TM, Han S, Bryant RV. Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic. J Gastroenterol Hepatol. 2020.
3. Mehta B, Jannat-Khah D, Mancuso CA, et al. Geographical variations in COVID-19 perceptions and patient management: a national survey of rheumatologists. Semin Arthritis Rheum. 2020;50(5):1049-1054.
4. Agrawal M, Brenner EJ, Zhang X, Colombel JF, Kappelman MD, Ungaro RC. Physician practice patterns on holding inflammatory bowel disease medications due to COVID-19 in the SECURE-IBD registry. J Crohns Colitis. 2020.
5. Certain Medical Conditions and Risk for Severe COVID-19 illness. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html#immunocompromised-state. Accessed 2/22/2021.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献